501 filings
Page 5 of 26
8-K
lyr1x
8 Feb 19
Other Events
5:34pm
DEFA14A
xqw69oj4fbvzhwd
8 Feb 19
Additional proxy soliciting materials
5:30pm
PX14A6G
xpa816d3dwzjzw4yx
8 Feb 19
Letter to shareholders
12:17pm
8-K
lnh2qz6hy6 th9m
29 Jan 19
Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results
7:15am
8-K
tnp8wn5r
25 Jan 19
Other Events
5:07pm
8-K
m7t0ymy30pgf2mdpd7p
15 Nov 18
Entry into a Material Definitive Agreement
4:31pm
8-K
ynooksdzls4tgq
13 Nov 18
Entry into a Material Definitive Agreement
5:03pm
424B2
rrf1tw8io0a s46ab0b
9 Nov 18
Prospectus for primary offering
5:24pm
424B5
99eziwli0pj vnxrgzm
8 Nov 18
Prospectus supplement for primary offering
6:08am
8-K
jbpkbcj
1 Nov 18
Regulation FD Disclosure
12:00am
8-K
rf6j1
30 Oct 18
Allergan Reports Third Quarter 2018 Results Including GAAP Net Revenues of $3.9 Billion
6:45am
8-K
p83yjj6d53big416zqsk
29 Aug 18
Departure of Directors or Certain Officers
12:00am
8-K
l5f4vou1ciefcop519cp
8 Aug 18
Departure of Directors or Certain Officers
4:16pm
8-K
m3ik8ek u6i4
26 Jul 18
Allergan Reports Strong Second Quarter 2018 Results Including GAAP Net Revenues of $4.1 Billion
6:45am
8-K
d2kul1mq34wwqdkr
14 Jun 18
Departure of Directors or Certain Officers
12:00am
SD
run0dn75pje
31 May 18
Conflict minerals disclosure
4:16pm